Testicular Tissue Banking for Fertility Preservation in Young Boys: Which Patients Should Be Included?
- PMID: 35360062
- PMCID: PMC8960265
- DOI: 10.3389/fendo.2022.854186
Testicular Tissue Banking for Fertility Preservation in Young Boys: Which Patients Should Be Included?
Abstract
Due to the growing number of young patients at risk of germ cell loss, there is a need to preserve spermatogonial stem cells for patients who are not able to bank spermatozoa. Worldwide, more and more clinics are implementing testicular tissue (TT) banking programs, making it a novel, yet indispensable, discipline in the field of fertility preservation. Previously, TT cryopreservation was predominantly offered to young cancer patients before starting gonadotoxic chemo- or radiotherapy. Nowadays, most centers also bank TT from patients with non-malignant conditions who need gonadotoxic conditioning therapy prior to hematopoietic stem cell (HSCT) or bone marrow transplantation (BMT). Additionally, some centers include patients who suffer from genetic or developmental disorders associated with prepubertal germ cell loss or patients who already had a previous round of chemo- or radiotherapy. It is important to note that the surgical removal of TT is an invasive procedure. Moreover, TT cryopreservation is still considered experimental as restoration methods are not yet clinically available. For this reason, TT banking should preferably only be offered to patients who are at significant risk of becoming infertile. In our view, TT cryopreservation is recommended for young cancer patients in need of high-risk chemo- and/or radiotherapy, regardless of previous low-risk treatment. Likewise, TT banking is advised for patients with non-malignant disorders such as sickle cell disease, beta-thalassemia, and bone marrow failure, who need high-risk conditioning therapy before HSCT/BMT. TT retrieval during orchidopexy is also proposed for patients with bilateral cryptorchidism. Since patients with a medium- to low-risk treatment generally maintain their fertility, TT banking is not advised for this group. Also for Klinefelter patients, TT banking is not recommended as it does not give better outcomes than a testicular sperm extraction later in life.
Keywords: (non-)malignant disease; fertility preservation; germ cell loss; immature testicular tissue banking; male infertility; prepubertal boys; spermatogonial stem cells; testis.
Copyright © 2022 Delgouffe, Braye and Goossens.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
A European perspective on testicular tissue cryopreservation for fertility preservation in prepubertal and adolescent boys.Hum Reprod. 2015 Nov;30(11):2463-75. doi: 10.1093/humrep/dev190. Epub 2015 Sep 10. Hum Reprod. 2015. PMID: 26358785 Review.
-
Spermatogonial quantity in human prepubertal testicular tissue collected for fertility preservation prior to potentially sterilizing therapy.Hum Reprod. 2018 Sep 1;33(9):1677-1683. doi: 10.1093/humrep/dey240. Hum Reprod. 2018. PMID: 30052981 Free PMC article.
-
Cryopreservation of testicular tissue or testicular cell suspensions: a pivotal step in fertility preservation.Hum Reprod Update. 2016 Nov;22(6):744-761. doi: 10.1093/humupd/dmw029. Epub 2016 Aug 27. Hum Reprod Update. 2016. PMID: 27566839 Free PMC article. Review.
-
Childhood cancer and hematological disorders negatively affect spermatogonial quantity at diagnosis: a retrospective study of a male fertility preservation cohort.Hum Reprod. 2023 Mar 1;38(3):359-370. doi: 10.1093/humrep/dead004. Hum Reprod. 2023. PMID: 36708005 Free PMC article.
-
Fertility preservation in boys: recent developments and new insights †.Hum Reprod Open. 2020 Jun 6;2020(3):hoaa016. doi: 10.1093/hropen/hoaa016. eCollection 2020. Hum Reprod Open. 2020. PMID: 32529047 Free PMC article.
Cited by
-
Germline stem cells in human.Signal Transduct Target Ther. 2022 Oct 2;7(1):345. doi: 10.1038/s41392-022-01197-3. Signal Transduct Target Ther. 2022. PMID: 36184610 Free PMC article. Review.
-
Fertility Preservation in Pediatric Age: Future Perspective among Andrological Diseases.Life (Basel). 2023 Sep 20;13(9):1934. doi: 10.3390/life13091934. Life (Basel). 2023. PMID: 37763337 Free PMC article. Review.
-
In vivo and in vitro sperm production: an overview of the challenges and advances in male fertility restoration.Clin Exp Reprod Med. 2024 Sep;51(3):171-180. doi: 10.5653/cerm.2023.06569. Epub 2024 Mar 25. Clin Exp Reprod Med. 2024. PMID: 38525520 Free PMC article.
-
Bridging the Gap: Animal Models in Next-Generation Reproductive Technologies for Male Fertility Preservation.Life (Basel). 2023 Dec 21;14(1):17. doi: 10.3390/life14010017. Life (Basel). 2023. PMID: 38276265 Free PMC article. Review.
-
Testicular extracellular matrix/gelatin-based scaffold using gas foaming to support spermatogonial stem cells.Iran J Basic Med Sci. 2025;28(8):1107-1118. doi: 10.22038/ijbms.2025.83885.18150. Iran J Basic Med Sci. 2025. PMID: 40584446 Free PMC article.
References
-
- Vassal G, Schrappe M, Pritchard-Jones K, Arnold F, Basset L, Biondi A, et al. . The SIOPE Strategic Plan: A European Cancer Plan for Children and Adolescents. J Cancer Policy (2016) 8:17–32. doi: 10.1016/j.jcpo.2016.03.007 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources